Kailera
Clinical trials sponsored by Kailera, explained in plain language.
-
New weekly shot could outperform ozempic for obesity
Disease control Recruiting nowThis study tests a new weekly injection, KAI-9531, to see if it helps people with obesity lose more weight than semaglutide (the drug in Ozempic/Wegovy) or a placebo. About 1,200 adults with a BMI of 35 or higher who have tried and failed to lose weight through diet and exercise …
Phase: PHASE3 • Sponsor: Kailera • Aim: Disease control
Last updated May 16, 2026 06:50 UTC
-
New weekly shot could help people with severe obesity shed pounds
Disease control Recruiting nowThis study tests a new medicine called KAI-9531, given as a weekly shot, to help people with obesity lose weight. About 250 adults with a BMI of 35 or higher who have tried and failed to lose weight through diet and exercise in the past 6 months will take part. Participants will …
Phase: PHASE2 • Sponsor: Kailera • Aim: Disease control
Last updated May 16, 2026 06:49 UTC
-
New weekly shot could help people with obesity and diabetes shed pounds and lower blood sugar
Disease control Recruiting nowThis study tests a new medicine called KAI-9531, given as a weekly shot, to see if it helps people with obesity and type 2 diabetes lose weight and improve blood sugar control. About 1,700 adults who have tried and failed to lose weight before will take part. The study compares t…
Phase: PHASE3 • Sponsor: Kailera • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
New daily pill could help shed pounds in obesity trial
Disease control Recruiting nowThis study tests an experimental daily pill called KAI-7535 to see if it helps people with obesity or overweight lose more weight than a placebo. The trial includes 320 adults who also have at least one weight-related health problem like high blood pressure or sleep apnea. Partic…
Phase: PHASE2 • Sponsor: Kailera • Aim: Disease control
Last updated May 15, 2026 11:54 UTC